Population
69 patients with primary breast angiosarcoma seen between 1965 and 2002, median age 46
Design
Cohort
Follow-up
Median 40 months (range, 0-413 months)
Authors
Loading...
Highlights high recurrence risk in breast angiosarcoma; leaves open optimal systemic strategies pending prospective trials.
Breast angiosarcoma is frequently advanced at diagnosis with a tendency for local-regional recurrence, though chemotherapy shows significant response rates in the metastatic setting.
Sher et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: